Yasir S. Raouf

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

Krimo Toutah, Nabanita Nawar, Sanna Timonen et al. · Journal of Medicinal Chemistry · 2021 · 43 citations · Full text

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia

Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf et al. · European Journal of Medicinal Chemistry · 2020 · 40 citations · Full text

Hematological Malignancy, Oncology, Medicine +11

Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting

Muhammad Murtaza Hassan, Johan Israelian, Nabanita Nawar et al. · Journal of Medicinal Chemistry · 2020 · 38 citations · Full text

Combinatorial Chemistry, Histone Deacetylases, Medicinal Chemistry +15

Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer

Andrew E. Shouksmith, Fenil Shah, Michelle Grimard et al. · Journal of Medicinal Chemistry · 2019 · 36 citations · Full text

Hdac Inhibitors, Pathology, Hdac Drug +16

Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma

Nabanita Nawar, Shazreh Bukhari, Ashley Adile et al. · Journal of Medicinal Chemistry · 2022 · 29 citations · Full text